CRS Studies for CAR T Cell Therapy

Targeting Natural Killer Cell Activity With Humanized NSG IL15 Mouse Model

You save (%)

Select Options

Syngeneic Tumor Studies

You save (%)

Select Options

CD34+ Hu-NSG-FLT3

You save (%)

Select Options

A New Way to Study Cytokine Release Syndrome

You save (%)

Select Options

In Vivo Safety and Efficacy Platform for Immunotherapies

You save (%)

Select Options

In Vivo Evaluation Of Bispecific T-Cell Engager Efficacy & Safety

You save (%)

Select Options

Achieving Relevant Preclinical Characterization of CAR T Cell Therapies

You save (%)

Select Options

Humanized Mouse Models

You save (%)

Select Options